Mitsubishi Electric Research Laboratories (MERL) is Mitsubishi Electric Corporation's North American research organization that conducts application-motivated basic and applied research and advanced development in areas such as physical simulation & modeling, optimization, control, signal processing, and Artificial Intelligence.

Mitsubishi Electric Research Laboratories (MERL)

Adaptive Phage Therapeutics (APT) is a clinical-stage biotechnology company focused on developing safe, effective, and durable antimicrobial therapeutics to combat bacterial infections, particularly multi-drug resistant (MDR) pathogens.

Adaptive Phage Therapeutics

VentureSCALE is an accelerator focused on helping B2B startups build predictable, repeatable, and sustainable sales and revenue infrastructure. The program is designed for early-stage founders.

VentureSCALE

The Allen Institute for AI (AI2) is a non-profit research institute founded in 2014 with the mission of conducting high-impact AI research and engineering in service of the common good. Headquartered in Seattle, AI2 employs diverse scientific and engineering talent to tackle complex challenges in AI. The institute has undertaken ambitious projects to drive fundamental advances in science, medicine, and conservation through AI.

Metric
Company Name	Mitsubishi Electric Research Laboratories (MERL)	Adaptive Phage Therapeutics	VentureSCALE	Allen Institute for AI (AI2)
Symbol
MSH ID	COM:MERL	COM:APHAGE	IO:VENTURESCALE	ORG:ALLENAI
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Technology	Healthcare & Health Services	Commercial & Professional Services	Non-profit Research
Industry	Research and Development	Biotechnology	Tech Accelerators	Artificial Intelligence Research and Engineering
Country	US		US	US
Stage
Employee Count		51		323
Website	merl.com	aphage.com	venturescale.io	allenai.org
LinkedIn				allen-ai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MERL

Mitsubishi Electric Research Laboratories (MERL)

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue